{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:52:58Z","timestamp":1794073978210,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","award":["668031"],"award-info":[{"award-number":["668031"]}],"id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1053\/j.gastro.2025.10.005","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T09:20:17Z","timestamp":1766395217000},"page":"803-814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease"],"prefix":"10.1053","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4378-6256","authenticated-orcid":false,"given":"Nikolaj","family":"Torp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Lyngbeck","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Maagaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Semmler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette Lehmann","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Bech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helle","family":"Schnefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine Prier","family":"Lindvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine Holtz","family":"Thorhauge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Elise","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne Kragh","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida Falk","family":"Villesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Lerb\u00e6k","family":"Bergmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Julie","family":"Leeming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla Dalby","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja","family":"Thiele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9443-5846","authenticated-orcid":false,"given":"Mads","family":"Israelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Krag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2025.10.005_bib1","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2025.10.005_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL\u2013Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2025.10.005_bib3","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL\u2013EASD\u2013EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41575-024-01022-y","article-title":"The steatotic liver disease burden paradox: unravelling the key role of alcohol","volume":"22","author":"Torp","year":"2025","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2468-1253(24)00427-8","article-title":"Reporting discrepancy of alcohol intake affecting estimated prevalence of MetALD and ALD","volume":"10","author":"Krag","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib6","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cgh.2024.01.006","article-title":"Misclassified ALD is common in presumed MASLD and highly increases risk for future cirrhosis","volume":"22","author":"Nasr","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib7","article-title":"Quantification of alcohol intake in patients with steatotic liver disease and excessive alcohol intake","volume":"7","author":"Hansen","year":"2025","journal-title":"JHEP Rep"},{"key":"10.1053\/j.gastro.2025.10.005_bib8","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/apt.18506","article-title":"Head-to-head comparison between phosphatidylethanol versus indirect alcohol biomarkers for diagnosis of MetALD versus MASLD: a prospective study","volume":"61","author":"Tavaglione","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.10.005_bib9","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jhep.2025.04.019","article-title":"Phosphatidylethanol levels distinguish steatotic liver disease subgroups and are associated with risk of major liver outcomes","volume":"83","author":"Vaz","year":"2025","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib10","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1016\/j.cgh.2024.07.003","article-title":"Expert panel recommendations: practical clinical applications for initiating and monitoring resmetirom in patients with MASH\/NASH and moderate to noncirrhotic advanced fibrosis","volume":"22","author":"Noureddin","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib11","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2018.01.005","article-title":"Accuracy of the enhanced liver fibrosis test vs fibrotest, elastography, and indirect markers in detection of advanced fibrosis in patients with alcoholic liver disease","volume":"154","author":"Thiele","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.10.005_bib12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/jat\/bkaa082","article-title":"Stability of phosphatidylethanol 16: 0\/18: 1 in freshly drawn, authentic samples from healthy volunteers","volume":"45","author":"Skr\u00e5stad","year":"2021","journal-title":"J Anal Toxicol"},{"key":"10.1053\/j.gastro.2025.10.005_bib13","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S2468-1253(25)00187-6","article-title":"Phosphatidylethanol and self-reported alcohol intake to classify MASLD, MetALD, and ALD in individuals at risk of steatotic liver disease: a prospective cohort study","volume":"10","author":"Torp","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib14","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/dta.3340","article-title":"Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 Consensus of Basel)","volume":"14","author":"Luginbuhl","year":"2022","journal-title":"Drug Test Anal"},{"key":"10.1053\/j.gastro.2025.10.005_bib15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jhep.2024.11.028","article-title":"Metabolic dysfunction and alcohol-related liver disease (MetALD): position statement by an expert panel on alcohol-related liver disease","volume":"82","author":"Arab","year":"2025","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib16","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/hep.30163","article-title":"ADAPT: an algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis","volume":"69","author":"Daniels","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.10.005_bib17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/apt.16513","article-title":"PRO-C3 and ADAPT algorithm accurately identify patients with advanced fibrosis due to alcohol-related liver disease","volume":"54","author":"Madsen","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2025.10.005_bib18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib19","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/hep.27598","article-title":"The clinical course of cirrhosis: the importance of multistate models and competing risks analysis","volume":"62","author":"Jepsen","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2025.10.005_bib20","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.jhep.2025.05.030","article-title":"Clinical utility of phosphatidylethanol to detect underreported alcohol use and enhance steatotic liver disease subclassification","volume":"83","author":"Tavaglione","year":"2025","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/00365521.2016.1239759","article-title":"Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease","volume":"52","author":"Hagstr\u00f6m","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.10.005_bib22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/liv.14390","article-title":"Collagen biology and non-invasive biomarkers of liver fibrosis","volume":"40","author":"Karsdal","year":"2020","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2025.10.005_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3748\/wjg.v19.i4.516","article-title":"Effect of alcohol consumption on liver stiffness measured by transient elastography","volume":"19","author":"Bardou-Jacquet","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2025.10.005_bib24","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S2468-1253(18)30124-9","article-title":"Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis","volume":"3","author":"Nguyen-Khac","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.addbeh.2016.11.025","article-title":"Assessment reactivity: a randomized controlled trial of alcohol-specific measures on alcohol-related behaviors","volume":"67","author":"Meier","year":"2017","journal-title":"Addict Behav"},{"key":"10.1053\/j.gastro.2025.10.005_bib26","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2468-1253(23)00206-6","article-title":"MetALD: new opportunities to understand the role of alcohol in steatotic liver disease","volume":"8","author":"Israelsen","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib27","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.cgh.2020.11.038","article-title":"Metabolic and genetic risk factors are the strongest predictors of severity of alcohol-related liver fibrosis","volume":"20","author":"Israelsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib28","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.cgh.2025.02.007","article-title":"Steatotic liver disease classification is dynamic, affecting clinical trial eligibility and subclass-specific treatments","volume":"23","author":"Israelsen","year":"2025","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib29","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1053\/j.gastro.2024.02.032","article-title":"Impact of longitudinal alcohol use patterns on long-term risk of cirrhosis among US veterans with steatotic liver disease","volume":"166","author":"Wong","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2025.10.005_bib30","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jhep.2022.11.013","article-title":"Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort","volume":"78","author":"Louvet","year":"2023","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2025.10.005_bib31","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41591-023-02383-8","article-title":"Alcohol consumption and risks of more than 200 diseases in Chinese men","volume":"29","author":"Im","year":"2023","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2025.10.005_bib32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/sim.4348","article-title":"Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models","volume":"31","author":"Pencina","year":"2012","journal-title":"Stat Med"},{"key":"10.1053\/j.gastro.2025.10.005_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/acer.12248","article-title":"The relationship between excessive alcohol consumption and alcohol use disorders according to DSM-IV and DSM-5","volume":"38","author":"Tuithof","year":"2014","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1053\/j.gastro.2025.10.005_bib34","article-title":"Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trial","volume":"54","author":"S\u00f6derpalm","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1053\/j.gastro.2025.10.005_bib35","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.cca.2011.04.022","article-title":"Method development for routine liquid chromatography\u2013mass spectrometry measurement of the alcohol biomarker phosphatidylethanol (PEth) in blood","volume":"412","author":"Zheng","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1053\/j.gastro.2025.10.005_bib36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/acer.13620","article-title":"Differences in the synthesis and elimination of phosphatidylethanol 16: 0\/18: 1 and 16: 0\/18: 2 after acute doses of alcohol","volume":"42","author":"Hill-Kapturczak","year":"2018","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525061207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508525061207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T09:18:03Z","timestamp":1773998283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508525061207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0016508525061207"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2025.10.005","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Performance of Phosphatidylethanol With Noninvasive Liver Fibrosis Tests in Alcohol-Related Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2025.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}